Results for "consumer data right"
641-650 of 847 results for 'consumer data right'
October compliance deadlines: rounding up the last-minute changes
October marks the commencement of the design and distribution obligations (DDO) regime, the deferred sales model for add-on insurance (DSM), changes to the anti-hawking rules, refreshed standards for internal dispute resolution systems and, to top it all off, a new breach reporting regime. ...
Significant new climate change requirements for NSW premises
From 2026, the NSW Environment Protection Authority (EPA) will play a significantly greater role in regulating greenhouse gas (GHG) emissions in NSW. Environment Protection Licences (EPLs) will become ...
How to prepare for, and execute, a successful exit
After a relatively subdued 2023, we are predicting that the rest of 2024 will prove to be the year of the exit, with improving macroeconomic conditions providing the ideal environment for the exit of a number of high-quality assets. ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
Failure to pay patent renewal fee? Advanta can take advantage of extension of time provision
Advanta Seeds Pty Ltd (Advanta), a broadacre seed company that owns thousands of patents relating to agricultural chemicals, seeds and seed technologies, applied for review of a decision by the Commissioner of Patents refusing its application under s 223 Patents Act 1990 (Cth) (Patents Act) for an e ...
Priority window closes soon for .au direct domain names
Further to our last update, the window for existing holders of .au domain names (eg .com.au or .net.au) to claim priority status to register matching .au direct names (eg 'allens.au' instead of 'allens.com.au') closes on 20 September 2022. ...
A battle with Banksy
Banksy has lost his trade mark rights to his notorious Flower Thrower artwork in the EU. The EUIPO's decision reflects on bad faith registrations in the EU and offers other important food for thought in the context of trade mark and copyright law. ...
A positive result for diagnostic method patents in Australia
In the highly anticipated decision Sequenom, Inc. v Ariosa Diagnostics, Inc. [2019] FCA 1011, the Federal Court has confirmed that diagnostic methods remain patent-eligible subject matter in Australia … at least for now. ...
InIP: What's happening in intellectual property - April 2023
Your regular wrap-up of some of the world's leading and intriguing IP stories. ...
The mRNA rush
There is great potential for mRNA technology to revolutionise future vaccines, and treatment of various conditions such as rare genetic disorders, other infectious diseases and even cancer. The enthusiasm for the technology – or the 'mRNA rush' – is reflected by a spike in patent filings over the past five years, and the growing patent portfolios of key mRNA pioneers and market players. ...